Left ventricular hypertrophy (LVH) is a powerful cardiovascular risk factor and has previously been related to endothelium-dependent vasodilation (EDV) in hypertensive patients. In the Prospective Investigation of the Vasculature in Uppsala Seniors study, different techniques to evaluate EDV in different types of vessels were applied and were related to left ventricular mass index (LVMI) in the general population. In 1016 subjects aged 70 years, EDV was evaluated by the invasive forearm technique with acetylcholine given in the brachial artery, the brachial artery ultrasound technique with measurement of flow-mediated dilatation (FMD) and the pulse wave analysis method with b-2-agonist (terbutaline) provocation. LVMI was determined by echocardiography. LVMI was related to both EDV and the pulse wave-based technique (both r ¼ À0.14, Po0.0001) in univariate analysis. LVMI was also weakly related to FMD (r ¼ À0.07, P ¼ 0.046). However, in multiple regression analysis adjusted for gender, systolic and diastolic blood pressure and use of antihypertensive medication, only EDV was associated with LVMI (P ¼ 0.016). EDV was mainly reduced in those with left ventricular concentric hypertrophy (P ¼ 0.0012). In conclusion, in a population-based sample of elderly subjects, EDV, but not FMD, was inversely correlated with LVM independent of blood pressure, suggesting that EDV in resistance arteries is of more importance for LVH than endothelial vasodilatory function in conduit arteries in the elderly.
Introduction
An increased left ventricular mass index (LVMI) has been shown to predict future cardiovascular events in prospective studies, both in hypertensive subjects and in the general population. 1, 2 Although left ventricular hypertrophy (LVH) could result from aortic valve stenosis and other rare abnormalities, hypertension is the factor most closely related to LVH.
Endothelium-dependent vasodilation (EDV) is a characteristic feature of the vasculature and an impaired EDV is seen early in the atherosclerotic process 3 and also in the early stages of arterial hypertension. 4 As with LVH, a defect EDV has also been shown to predict future cardiovascular events. 5, 6 Previous studies have shown LVH to be related to an impaired EDV in hypertensive subjects. [7] [8] [9] [10] [11] [12] [13] [14] However, the relationship between EDV and LVMI has not been investigated in a general population. Furthermore, as the degree of EDV in peripheral conductance arteries and resistance arteries are not closely related, [15] [16] [17] there is a need to clarify the relationship between EDV in these two types of arteries and LVMI in the same individuals.
The Prospective Investigation of the Vasculature in Uppsala Seniors (the PIVUS study) was conducted with the primary aim to evaluate the power of three different tests of EDV in the peripheral circulation to predict future cardiovascular events in more than 1000 subjects aged 70 living in the community of Uppsala, Sweden. 17 As this primary aim demands a long follow-up period, we here report one of the secondary aims of the study, namely to evaluate the relationships between LVMI and measurements of EDV in both resistance vessels and in a conduit artery.
Materials and methods

Subjects
All subjects aged 70 living in the community of Uppsala, Sweden. The subjects were chosen from the register of community living and were invited in a randomized order. The subjects received an invitation by letter within 2 months of their 70th birthday. The PIVUS study aimed to investigate the elderly population and standardized the age at 70 years to have the same age in all subjects, as age is such an important characteristic, especially in the elderly. Of the 2025 subjects invited, 1016 subjects participated giving a participation rate of 50.1%.
The study was approved by the ethics committee of the University of Uppsala and the participants gave informed consent (Table 1) .
Basic investigation
The participants were asked to answer a questionnaire about their medical history, smoking habits and regular medication at home before the examination. Thus, the data given in Table 2 in these matters were self-reported by the participants.
All subjects were investigated in the morning after fasting since midnight, giving a fasting period of at least 9 h. No medication or smoking was allowed after midnight. After recordings of height, weight, abdominal and hip circumference, an arterial cannula was inserted in the brachial artery for blood sampling and later regional infusions of vasodilators. During the investigation, the subjects were supine in a quiet room maintained at a constant temperature of 22 1C.
Blood pressure was measured by a calibrated mercury sphygmomanometer in the non-cannulated arm to nearest mm Hg after at least 30 min of rest and the average of three recordings was used. Lipid variables and fasting blood glucose were measured by standard laboratory techniques.
As the participation rate in this cohort was only 50%, we carried out an evaluation of cardiovascular disorders and medications in 100 consecutive nonparticipants. The prevalences of cardiovascular drug intake, history of myocardial infarction, coronary revascularization, antihypertensive medication, statin use and insulin treatment were similar to those in the investigated sample, whereas the prevalences of diabetes, congestive heart failure and stroke tended to be higher among the non-participants (see Table 2 ). Abbreviations: CABG/PTCA, coronary revascularisation; CV, cardiovascular; GTN, any nitroglycerine preparation.
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Methods
The invasive forearm technique. Forearm blood flow (FBF) was measured by venous occlusion plethysmography (Elektromedicin, Kullavik, Sweden). A mercury in silastic strain gauge was placed at the upper third of the forearm, which rested comfortably slightly above the level of the heart. The strain gauge was connected to a calibrated plethysmograph. Venous occlusion was achieved by a blood pressure cuff applied proximal to the elbow and inflated to 50 mm Hg by a rapid cuff inflator. Evaluations of FBF were made by calculations of the mean of at least five consecutive recordings. An arterial cannula was placed in the brachial artery. No more than one attempt to insert the cannula in each arm was allowed. Resting FBF was measured 30 min after cannula insertion. After evaluation of resting FBF, local intra-arterial drug infusions were given during 5 min for each dose with a 20 min washout period between the drugs. The infused dosages were 25 and 50 mg min À1 for acetylcholine (Clin-Alpha, Switzerland) to evaluate EDV and 5 and 10 mg min À1 for sodium nitroprusside (SNP, Nitropress; Abbot, UK) to evaluate endothelium-independent vasodilation (EIDV). The dosages of these drugs have been chosen to result in FBFs on the steep part of the dose-response curve without giving systemic effects. The drugs were given in a random order at a maximal rate of 1 ml min À1 . In the present study only data from the highest doses of acetylcholine and SNP were used. EDV was defined as: (FBF during infusion of 50 mg min À1 of acetylcholine minus resting FBF) divided by resting FBF. EIDV was defined as FBF during infusion of 10 mg min À1 of SNP minus resting FBF divided by resting FBF.
We did not use any distal cuff to exclude the hand circulation during measurements of EDV to avoid the discomfort and increase in sympathetic drive caused by this procedure. We have previously shown that almost identical results are obtained when FBF is measured with or without hand cuff in the resting state, or during infusion of SNP or another muscarinic receptor agonist, methacholine. 18 EDV and EIDV could successfully been evaluated in 87% of the participants of the study. In the 3% on Warfarin treatment no cannulation was performed and in 10% the cannulation failed. We have previously shown the reproducibility (coefficient of variation, CV) for EDV and EIDV to be 8-10%. 18 The brachial artery ultrasound technique. The brachial artery was assessed by external B-mode ultrasound imaging 2-3 cm above the elbow (Acuson, 7.0 MHz linear transducer; Acuson, Mountain View, CA, USA) according to the recommendations of the International Brachial Artery Task Force. 19 Depths and gains settings were optimized to identify the lumen to vessel wall interface. The subject rested in the supine position for at least 30 min before the first scan and remained supine during the evaluation. Blood flow increase was induced by inflation of a pneumatic cuff placed around the forearm to a pressure at least 50 mm Hg above systolic blood pressure. When the cuff was rapidly deflated 5 minutes later, the artery was scanned continuously for 90 s and recorded on a super-VHS videotape and the diameter was later analysed with callipers at the peak of the R-wave for later analysis at the diameter. Flow-mediated dilatation (FMD) was defined as the maximal brachial artery diameter recorded between 30 and 90 s following cuff release minus diameter at rest divided by the diameter at rest.
FMD was successfully evaluated in 97% of the participants.
We have previously shown the reproducibility (CV) to be 3% for baseline brachial artery diameter and 29% for FMD. 15 Pulse wave analysis. A micromanometer-tipped probe (Sphygmocor; Pulse Wave Medical Ltd, Australia) was applied to the surface of the skin overlying the radial artery and the peripheral radial pulse wave was continuously recorded. The mean values of around 10 pulse waves were used for analyses. Recordings were regarded as satisfactory if the variations in the systolic peak and the diastolic peak were 5% or below. Only three attempts to achieve a satisfactory recording were allowed. The maximal systolic peak and the reflected waves were identified by the calculations of the first and second derivative of the pulse curve. After a baseline recording, terbutaline was subcutaneously administered (0.25 mg in the upper part of the arm) and a reevaluation of the pulse wave was performed after 15 and 20 min. We had previously found that the maximal alterations in the pulse waveform occurred after 15 min in young healthy subjects, 20 but we also performed a measurement after 20 min in this sample of elderly subjects. Thus, the maximal change occurring at either 15 or 20 min was used for calculations.
We have previously validated the response of the relative height of diastolic reflected wave (denoted reflection index, RI) to terbutaline as a marker of endothelial vasodilatory function, as the response is blocked by N(G)-monomethyl-L-arginine (L-NMMA). 20 Here, we report these three variables as changes relative changes from baseline following terbutaline. Thus, a large reduction of the RI indicates a good response. The change in the RI could successfully be evaluated in 86% of the sample. We have previously shown the reproducibility (CV) for the change in RI to be 9.4%. 20 The three different techniques to evaluate EDV were evaluated by three different persons not aware of the results of the other techniques or any other data. The adverse events recorded as a consequence of the vasodilatory procedures were a local haematoma at site of the cannulation of the brachial artery occurring in approximately 10% of the subjects.
There were also three cases of fainting following terbutaline injection (see reference Lind et al. LVM was determined from the Penn convention and indexed for height 2.7 21,22 to obtain LVMI. LV geometry was also divided into four categories according to Ganau et al. 21 A normal LV geometry was considered to be present if LVMI was normal (o51 g/m 2.7 ) and RWT o0.45. 21 Concentric LVH was defined as LVMI above the threshold for LVH together with RWT40.44, but if RWT was below this cutoff for RWT eccentric LVH was present. If LVMI was normal but RWT40.45, the LV geometry was denoted concentric remodelling.
Subjects with valvular disease, cardiomyopathies and amyloidosis were excluded from the investigated sample (n ¼ 23).
The evaluation of the different vasodilatory techniques and echocardiography was performed by different technicians not aware of the other collected data.
Statistics. Non-normally distributed variables were log-transformed to achieve a normal distribution. Differences between groups were evaluated with analysis of variance (ANOVA) with Bonferroni post hoc analysis. Relationships between pairs of variables were evaluated by Pearson's correlation coefficient. Multiple regression analysis was applied to relate several independent variables to a dependent variable. Two-tailed significance values were given with Po0.05 regarded as significant. The statistical programme package StatView (SAS Inc, NC, USA) was used.
Results
LVM could be properly assessed in 91% of the sample. The 2.4% of the population with significant valve abnormalities were not included in the analysis.
The mean value for LVMI was 43 ± 13 g/m 2.7 in the total population, being 44 ± 13 in men and 42±13/g m 2.7 in the women. In the total population, LVMI was related to both EDV and the pulse wave-based technique (both r ¼ À0.14, P ¼ 0.0031) in univariate analysis. LVMI was also weakly related to FMD (r ¼ À0.07, Po0.046), as well as to EIDV (r ¼ -0.09, P ¼ 0.0061).
However, in multiple regression analysis when the effects of gender, systolic and diastolic blood pressure and use of antihypertensive medications were taken in account, only EDV was related to LVMI (P ¼ 0.013, see Table 3 for details). The corresponding P-values for change in RI, FMD and EIDV after correction for gender, systolic and diastolic blood pressure and use of antihypertensive medications were 0.12, 0.15 and 0.10, respectively.
When left ventricular geometry was divided in four groups according to Ganau et al., 21 a significant difference regarding EDV was seen between the groups (P ¼ 0.023; Figure 1 ). Post hoc analysis after correction for gender, systolic and diastolic blood pressure and use of antihypertensive medication showed the difference in EDV to mainly be between those with a normal left ventricle and those with concentric LVH (P ¼ 0.0012).
Discussion
The present study showed that EDV as evaluated by the invasive forearm technique, but not FMD, was related to LVMI independently of gender, blood pressure level or antihypertensive medication in a general elderly population.
Of the three different measurements of EDV evaluated in the present study, EDV was most 23 The two most powerful determinants of LVMI are hypertension and the use of antihypertensive medication. EDV has previously been found to be impaired by hypertension, [23] [24] [25] [26] [27] as well as to be influenced by antihypertensive medication, [28] [29] [30] but in the present study EDV was related to LVMI independently of these confounders, supporting the idea of an independent role for EDV on LVM.
Furthermore, an analysis of the different left ventricular geometric subgroups showed impairment in EDV mainly in those with left ventricular concentric hypertrophy, the 'classical' form of LVH. As the invasive forearm technique mainly assesses vasodilation in resistance vessels, it is likely that EDV in this type of vessels are of importance for the development of LVH, possibly by an increase in after load. However, prospective studies are needed to evaluate if an impaired EDV could predict the development of concentric LVH before any firm conclusions could be drawn.
In the present study, only a weak relationship was found between FMD and LVMI, not being present after correction for the blood pressure level. This is in agreement with a recently published study in which FMD was related to LVMI before, but not following correction for confounders. 7 However, there are two previous studies reporting a negative relationship with LVMI even after correction for blood pressure. 9, 10 One reason for these different findings might be that FMD becomes markedly reduced by age also in healthy elderly and it might therefore be hard to relate FMD to any physiological parameters when the range of values is very narrow. 31 Furthermore, it has recently been shown that FMD is influenced by arterial stiffness, 32 a condition often found in the elderly. FMD also has a poorer reproducibility than EDV, a fact that might produce less strong relationships between FMD and LVH when compared with EDV. Thus, at least in the elderly, FMD in the brachial artery is not a main determinant of LVH.
FMD has previously been shown to be related to coronary vasoreactivity. 33 However, the present lack of relationship between FMD and LVH in the present study does not exclude a vasodilatory dysfunction in the coronary conduit arteries in these elderly subjects with LVH, as this has been reported in the past. 33 We have previously shown the pulse wave response to terbutaline to be related to that of EDV, but not to FMD. 16, 17 This is not surprising as the change in RI mainly is due to vasodilation in resistance vessels, similar to that obtained by the forearm model. In the present study, the change in RI was found to be related to LVMI in the same manner as EDV. However, the change in RI did not retain its significance after correction for the blood pressure level, suggesting that the pulse wave-based response to terbutaline is heavily dependent on the blood pressure level.
Limitations of the study
The present sample is limited to caucasians aged 70. So, caution should be made to draw conclusions to other ethnic and age groups.
Furthermore, the present study had a moderate participation rate. An analysis of non-participants showed the present sample to be fairly representative of the total population regarding most cardiovascular disorders and drug intake. However, as in all population-based studies in the elderly, there was an overrepresentation of disabling disorders, such as stroke and heart failure, in those who did not attend.
The history of disorders and medication was selfreported by the participants and may therefore be subject to some uncertainties. EIDV was only assessed by one of the methods for practical and ethical reasons not to prolong the investigation procedure, as we would have had to give nitroglycerine (GNT) before terbutaline and would have had to wait for the withdrawal of the GNT effect. Furthermore, we have previously shown that EIDV evaluated by SNP infusion in the brachial artery and GNT-provoked change in brachial artery diameter are closely related, 15 so additional measurements of EIDV would probably not add substantial information to the study.
In conclusion, in a population-based sample of elderly subjects, EDV, but not FMD, was inversely correlated with LVM independent of blood pressure, suggesting that EDV in resistance arteries is of more importance for LVH than endothelial vasodilatory function in conduit arteries in the elderly. Endothelial function and LVH L Lind
